Ben Mayne

Ben Mayne is currently the Director at Gilead Sciences, having advanced through various roles in regulatory affairs over the years. They previously served as Senior Manager at Gilead Sciences and held positions at AstraZeneca and Baxter Healthcare, among others. Ben began their career with an internship at Boehringer Ingelheim and has accumulated extensive experience in the field. They are currently pursuing an H.BSc. in Biotechnology at Brock University and a Post-Graduate Diploma in Pharmaceutical Regulatory Affairs & Quality Operations at Seneca Polytechnic.